Many people with diabetes must check their blood sugar up to ten times per day or more, particularly type 1 diabetics like Elliot Gatt, the founder of Good Glucos. Because of the frequency required, treatment compliance is an issue for many. Additionally, consistency in testing as well as accuracy of the test can make the difference between life and death. Good Glucos solves both of these challenges by providing highly accurate testing supplies on subscription. However, this is just the start of Good Glucos’ mission to provide end-to-end diabetes management for all.
One in four medical appointments ends in a “no-show.” Financially, that’s a $16 billion loss annually to health clinics and hospitals not to mention the human and hidden costs associated with interrupted care as a result of missed appointments. SureShow is a patent-pending solution that replaces no-shows with billable telehealth visits resulting in better continuity of care as well as increased revenue for medical practices.